Chronic Kidney Disease

AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s

Aleksandra Bykova , Maria Serova , Maria Chashkina , et al

Read time: 22m 11s
EASD 24: Prespecified Analysis from the SELECT Trial

Helen Colhoun

Watch time: 5m 37s
ESC 24: FINE-HEART: Finerenone in HF & CKD

Muthiah Vaduganathan

Watch time: 4m 24s
ADA 24: FLOW Trial: Kidney Outcomes in Patients Treated with Semaglutide

Vlado Perkovic

Watch time: 5m 40s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s

Anjay Rastogi

HFA 24: FINE-HEART: Design & Baseline Characteristics

Muthiah Vaduganathan

Watch time: 4m 40s
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i

Muthiah Vaduganathan

Watch time: 5m 24s

James Burton

Andrew Frankel, Shelley Zieroth et al

Muthiah Vaduganathan

Sydney Tang et al

Andrew JS Coats, Stefan Anker

Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

Shelley Zieroth et al

Watch time: 20m 16s (3 videos)

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)

Anjay Rastogi

Andrew Frankel, Shelley Zieroth, , et al

Watch time: 1h 7m 6s

Navdeep Tangri, James Burton, David Wheeler et al

Paul Kalra

Watch time: 12m 41s (2 videos)

Andrew Frankel, Shelley Zieroth et al

Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s

Media

CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)
Heart Failure in Focus Podcast - Ep 6: Cardiorenal Care in Practice

Muthiah Vaduganathan, ,

Listen time: 20m 40s

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Paul Kalra

Watch time: 12m 41s (2 videos)
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s

Andrew JS Coats, Stefan Anker

Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

Shelley Zieroth et al

Watch time: 20m 16s (3 videos)

Media

AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s

Andrew JS Coats, Stefan Anker

EASD 24: Prespecified Analysis from the SELECT Trial

Helen Colhoun

Watch time: 5m 37s

Andrew Frankel, Shelley Zieroth, , et al

Watch time: 1h 7m 6s

Sydney Tang et al

Muthiah Vaduganathan

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s

James Burton

Watch time: 4m 58s (1 video)

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)

Ileana L Piña, Gianluigi Savarese, , et al

Ileana L Piña, Gianluigi Savarese, , et al

Articles

GLP-1RA in Different HFpEF Phenotypes

Aleksandra Bykova

,

Maria Serova

,

Maria Chashkina

,

Raisa Kosharnaya

,

Zukhra Salpagarova

,

Denis Andreev

,

Ilya Giverts

,

Published:

16 October 2024

Citation:

Cardiac Failure Review 2024;10:e14.

DOI:

https://doi.org/10.15420/cfr.2024.06
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 615
  • Downloads: Downloads 69
  • Read time: 22m 11s